158 related articles for article (PubMed ID: 220548)
1. Nephrogenous cyclic AMP as a parathyroid function test.
Broadus AE
Nephron; 1979; 23(2-3):136-41. PubMed ID: 220548
[TBL] [Abstract][Full Text] [Related]
2. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
Broadus AE; Deftos LJ; Bartter FC
J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
[TBL] [Abstract][Full Text] [Related]
3. [Suppressibility of parathyroid function in primary hyperparathyroidism as estimated by nephrogenous cyclic AMP (author's transl)].
Sohn HE; Yumita S; Unakami H; Miura R; Furukawa Y
Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):110-21. PubMed ID: 6282661
[TBL] [Abstract][Full Text] [Related]
4. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
[TBL] [Abstract][Full Text] [Related]
5. Serum ionized calcium, nephrogenous and total urinary cyclic AMP and urinary phosphate in normal subjects.
Thode J; Holmegaard SN; Siggaard-Andersen O
Scand J Clin Lab Invest; 1984 Apr; 44(2):111-8. PubMed ID: 6326252
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
Broadus AE; Mahaffey JE; Bartter FC; Neer RM
J Clin Invest; 1977 Oct; 60(4):771-83. PubMed ID: 197123
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.
Broadus AE; Dominguez M; Bartter FC
J Clin Endocrinol Metab; 1978 Oct; 47(4):751-60. PubMed ID: 233682
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog.
Fox J; Heath H
Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of the determination of nephrogenous cyclic AMP in the diagnosis of primary hyperparathyroidism].
Bill G; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1983 Mar; 113(9):327-30. PubMed ID: 6302835
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenous cyclic AMP and plasma parathyroid hormone in hypercalcaemia: the influence of renal function.
Bill G; Jacquet AF; Burckhardt P
Eur J Clin Invest; 1984 Jun; 14(3):227-32. PubMed ID: 6088250
[TBL] [Abstract][Full Text] [Related]
11. Possibility of elevated parathyroid function in patients with calcium-containing nephrolithiasis as compared with normal controls.
Kitamura T; Hirano Y; Ueda D; Niijima T
Eur Urol; 1987; 13(1-2):90-9. PubMed ID: 3034619
[TBL] [Abstract][Full Text] [Related]
12. Renal cyclic adenosine monophosphate: an accurate index of parathyroid function.
Drezner MK; Neelon FA; Curtis HB; Lebovitz HE
Metabolism; 1976 Oct; 25(10):1103-12. PubMed ID: 184364
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous glucagon on the urinary excretion of adenosine 3',5'-monophosphate in man and in rats. Evidence for activation of renal adenylate cyclase and formation of nephrogenous cAMP.
Rubinger D; Wald H; Friedlaender MM; Silver J; Popovtzer MM
Miner Electrolyte Metab; 1988; 14(4):211-20. PubMed ID: 2850459
[TBL] [Abstract][Full Text] [Related]
14. Abnormal responsiveness of nephrogenous cyclic AMP excretion following intravenously administered calcium in normocalcaemic squamous cell cancer patients.
Naafs MA; Hackeng WH; Koorevaar G; Silberbusch J
Bone Miner; 1988 Jul; 4(3):289-98. PubMed ID: 2847840
[TBL] [Abstract][Full Text] [Related]
15. A spot sample test for the estimation of urinary or nephrogenous cAMP in the evaluation of parathyroid function.
Kraiem Z; Glaser B; Rosenzweig A; Sheinfeld M; Ben-Ari J
Nephron; 1983; 35(4):264-6. PubMed ID: 6316183
[TBL] [Abstract][Full Text] [Related]
16. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension.
Papagalanis ND; Skopelitis P; Kourti A; Kostogianni G; Karabatsos A; Gennadiou M; Thomas S; Samartzis M; Mountokalakis T
Nephron; 1991; 59(2):226-31. PubMed ID: 1659670
[TBL] [Abstract][Full Text] [Related]
17. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
Bikle DD; Herman RH
J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
[TBL] [Abstract][Full Text] [Related]
18. Nonautonomy of parathyroid hormone and urinary cyclic AMP in primary hyperparathyroidism.
Monchik JM; Wray HL; Schaaf M; Earll JM
Am J Surg; 1977 Apr; 133(4):498-505. PubMed ID: 192097
[TBL] [Abstract][Full Text] [Related]
19. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
Pak CY; Oata M; Lawrence EC; Snyder W
J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
[TBL] [Abstract][Full Text] [Related]
20. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
Madvig P; Young G; Marcus R
J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
